These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 29039668)

  • 1. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions.
    Lacivita E; Perrone R; Margari L; Leopoldo M
    J Med Chem; 2017 Nov; 60(22):9114-9141. PubMed ID: 29039668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S; Golubchik P; Offen D; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental and Genetic Factors in Autism Spectrum Disorders: Special Emphasis on Data from Arabian Studies.
    Almandil NB; Alkuroud DN; AbdulAzeez S; AlSulaiman A; Elaissari A; Borgio JF
    Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30813406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder.
    Barone R; Rizzo R; Tabbì G; Malaguarnera M; Frye RE; Bastin J
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences.
    Peñagarikano O
    Exp Neurobiol; 2015 Dec; 24(4):301-11. PubMed ID: 26713078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin and Animal Models for Autism Spectrum Disorder.
    Wagner S; Harony-Nicolas H
    Curr Top Behav Neurosci; 2018; 35():213-237. PubMed ID: 28864977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for autism in 2017 and the consequential implications to drug discovery.
    Chadman KK
    Expert Opin Drug Discov; 2017 Dec; 12(12):1187-1194. PubMed ID: 28971687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do animal models hold value in Autism spectrum disorder (ASD) drug discovery?
    Chadman KK; Fernandes S; DiLiberto E; Feingold R
    Expert Opin Drug Discov; 2019 Aug; 14(8):727-734. PubMed ID: 31132011
    [No Abstract]   [Full Text] [Related]  

  • 11. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets.
    Yang P; Chang CL
    Curr Pharm Des; 2014; 20(32):5186-93. PubMed ID: 24410563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.
    Umbricht D; Del Valle Rubido M; Hollander E; McCracken JT; Shic F; Scahill L; Noeldeke J; Boak L; Khwaja O; Squassante L; Grundschober C; Kletzl H; Fontoura P
    Neuropsychopharmacology; 2017 Aug; 42(9):1914-1923. PubMed ID: 27711048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
    Lamy M; Erickson CA
    Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in endogenous brain allopregnanolone induces autism spectrum disorder (ASD)-like behavior in mice: A novel animal model of ASD.
    Ebihara K; Fujiwara H; Awale S; Dibwe DF; Araki R; Yabe T; Matsumoto K
    Behav Brain Res; 2017 Sep; 334():6-15. PubMed ID: 28743598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.
    Rizk M; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Mol Biol Rep; 2021 Mar; 48(3):2669-2686. PubMed ID: 33650079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin and Autism Spectrum Disorders.
    Yamasue H; Domes G
    Curr Top Behav Neurosci; 2018; 35():449-465. PubMed ID: 28766270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD).
    Liu H; Talalay P; Fahey JW
    CNS Neurol Disord Drug Targets; 2016; 15(5):602-13. PubMed ID: 27071792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder.
    Lotufo Denucci B; Silva de Lima L; Ferreira Lima Mota I; Rocha Madureira Azevedo J; Germino Veras L; Montenegro Luzardo Bicca JV; de Miranda Santana B; Beserra Pinheiro G; Gonçalves Coelho G; Mortari MR
    Reprod Toxicol; 2021 Dec; 106():82-93. PubMed ID: 34695561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
    Jobski K; Höfer J; Hoffmann F; Bachmann C
    Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder.
    Thom RP; Pereira JA; Sipsock D; McDougle CJ
    Curr Psychiatry Rep; 2021 Oct; 23(12):79. PubMed ID: 34643815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.